Why Pacira Pharmaceuticals Inc. Shares Burst Today

Although we don't believe intiming the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares in Pacira Pharmaceuticals dropped by more than 10% earlier today following news that the New Jersey District Attorney's office had issued a subpoena regarding the promotion of Pacira Pharmaceuticals Exparel.

So What : Pacira Pharmaceuticals gets the vast majority of its revenue from Exparel, a non-opioid pain killer with sales of $188.5 million during 2014. As a result, investors are right to worry about any potential threats to Exparel demand, particularly in light of Pacira Pharmaceuticals' recent stumble with the drug.

In March, Pacira Pharmaceuticals reported that the FDA had issued a complete response letter, rather than an approval, for the expanded use of Exparel as a nerve block for post-surgical pain relief. Currently, Exparel is approved as a single-dose treatment at the surgical site to produce post-surgical pain relief for up to 72 hours. Since Exparel is a non-opioid pain reliever, its use can reduce the need for patients to take opioids in the period immediately following surgery.

Now What: The news of a subpoena isn't too surprising given that government agencies have been scrutinizing the marketing practices of other companies that also market drugs for pain; but that doesn't diminish the fact that the subpoena creates uncertainty for investors.

Whether or not Pacira Pharmaceuticals violated marketing rules, there remains a significant need for effective pain medications, particularly those that work differently from opioids. For that reason, this subpoena isn't likely to end up reducing demand for Exparel. However, if wrongdoing is discovered, Pacira Pharmaceuticals could be subject to fines or penalties. For that reason, I'm content to sit on the sidelines, and wait to see how this news plays out.

This $19 trillion industry could destroy the Internet

One bleeding-edge technology is about to put the World Wide Web to bed. And if you act right away, it could make you wildly rich. Experts are calling it the single largest business opportunity in the history of capitalism... The Economist is calling it "transformative"... But you'll probably just call it "how I made my millions." Don't be too late to the party -- click here for one stock to own when the Web goes dark.

The article Why Pacira Pharmaceuticals Inc. Shares Burst Today originally appeared on

Todd Campbell has no position in any stocks mentioned. Todd owns E.B. Capital Markets, LLC. E.B. Capital's clients may or may not have positions in the companies mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days . We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy .

Copyright © 1995 - 2015 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos

    The Motley Fool

    Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. The company's name was taken from Shakespeare, whose wise fools both instructed and amused, and could speak the truth to the king -- without getting their heads lopped off.

    Learn More